Patrick Boyle, MD
The program was captured live and features Dr. Patrick Boyle. Dr. Boyle is Professor of Medicine at the University of New Mexico. Please visit www.naceonline.com for more information.
Our learning objectives for this webcast are to discuss early pathogenesis and prevention of type 2 diabetes, more effectively attain tight glucose control, and discuss recent outcomes trials on the development and progression of atherosclerosis in diabetes
Our speaker makes the following disclosures. Dr. Boyle is on the speaker's bureau for Eli Lilly and Company, Pfizer, Amylin, Merck, and Takeda Pharmaceuticals of North America.
